China Immunoassay Market

ID: MRFR/HC/48533-HCR 200 Pages Vikita Thakur Last Updated: September 17, 2026
China Immunoassay Market Research Report By Type (Enzyme-Linked Immunosorbent Assay, Radioimmunoassay, Fluorescent Immunoassay, Chemiluminescent Immunoassay, Western Blot), By Technology (Automated Immunoassay, Point of Care Immunoassay, Lateral Flow Assay), By Application (Clinical Diagnostics, Drug Development, Environmental Testing, Food Safety Testing) and By End Use (Hospitals, Diagnostic Laboratories, Pharmaceutical Companies, Academic Research Institutions) - Growth & Industry Forecast 2025 To 2035
China Immunoassay Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)3.87%
2024 Market Size$ 1,893.75 Million
2025 Market Size$ 1,967.04 Million
2035 Market Size$ 2,874 Million
Key Players
Abbott Laboratories
Roche Diagnostics
Siemens Healthineers
Thermo Fisher Scientific
Danaher Corporation
Bio-Rad Laboratories
Trends
  • Technological Advancements
  • Rising Demand for Point-of-Care Testing
  • Focus on Personalized Medicine
Opportunities
  • Government Initiatives and Funding
  • Rising Demand for Home Testing Kits
  • Increasing Prevalence of Chronic Diseases
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Life Sciences, BY Type (USD Million)
      1. 4.1.1 Enzyme-Linked Immunosorbent Assay
      2. 4.1.2 Radioimmunoassay
      3. 4.1.3 Fluorescent Immunoassay
      4. 4.1.4 Chemiluminescent Immunoassay
      5. 4.1.5 Western Blot
    2. 4.2 Life Sciences, BY Technology (USD Million)
      1. 4.2.1 Automated Immunoassay
      2. 4.2.2 Point of Care Immunoassay
      3. 4.2.3 Lateral Flow Assay
    3. 4.3 Life Sciences, BY Application (USD Million)
      1. 4.3.1 Clinical Diagnostics
      2. 4.3.2 Drug Development
      3. 4.3.3 Environmental Testing
      4. 4.3.4 Food Safety Testing
    4. 4.4 Life Sciences, BY End Use (USD Million)
      1. 4.4.1 Hospitals
      2. 4.4.2 Diagnostic Laboratories
      3. 4.4.3 Pharmaceutical Companies
      4. 4.4.4 Academic Research Institutions
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Life Sciences
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Abbott Laboratories (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Roche Diagnostics (CH)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Siemens Healthineers (DE)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Thermo Fisher Scientific (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Danaher Corporation (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Bio-Rad Laboratories (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Ortho Clinical Diagnostics (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 PerkinElmer (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 CHINA MARKET ANALYSIS BY TYPE
    3. 6.3 CHINA MARKET ANALYSIS BY TECHNOLOGY
    4. 6.4 CHINA MARKET ANALYSIS BY APPLICATION
    5. 6.5 CHINA MARKET ANALYSIS BY END USE
    6. 6.6 KEY BUYING CRITERIA OF LIFE SCIENCES
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF LIFE SCIENCES
    9. 6.9 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
    11. 6.11 SUPPLY / VALUE CHAIN: LIFE SCIENCES
    12. 6.12 LIFE SCIENCES, BY TYPE, 2024 (% SHARE)
    13. 6.13 LIFE SCIENCES, BY TYPE, 2024 TO 2035 (USD Million)
    14. 6.14 LIFE SCIENCES, BY TECHNOLOGY, 2024 (% SHARE)
    15. 6.15 LIFE SCIENCES, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
    16. 6.16 LIFE SCIENCES, BY APPLICATION, 2024 (% SHARE)
    17. 6.17 LIFE SCIENCES, BY APPLICATION, 2024 TO 2035 (USD Million)
    18. 6.18 LIFE SCIENCES, BY END USE, 2024 (% SHARE)
    19. 6.19 LIFE SCIENCES, BY END USE, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 China MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY TECHNOLOGY, 2025-2035 (USD Million)
      3. 7.2.3 BY APPLICATION, 2025-2035 (USD Million)
      4. 7.2.4 BY END USE, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

China Life Sciences Market Segmentation

Life Sciences By Type (USD Million, 2025-2035)

  • Enzyme-Linked Immunosorbent Assay
  • Radioimmunoassay
  • Fluorescent Immunoassay
  • Chemiluminescent Immunoassay
  • Western Blot

Life Sciences By Technology (USD Million, 2025-2035)

  • Automated Immunoassay
  • Point of Care Immunoassay
  • Lateral Flow Assay

Life Sciences By Application (USD Million, 2025-2035)

  • Clinical Diagnostics
  • Drug Development
  • Environmental Testing
  • Food Safety Testing

Life Sciences By End Use (USD Million, 2025-2035)

  • Hospitals
  • Diagnostic Laboratories
  • China Immunoassay Market Companies
  • Academic Research Institutions

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.